Evidence map›Paper›PMID 37932224›Full record

ArticleJournal of gastric cancer2023

Impact of Coronavirus Disease 2019 on Gastric Cancer Diagnosis and Stage: A Single-Institute Study in South Korea.

Moonki Hong, Mingee Choi, JiHyun Lee, Kyoo Hyun Kim, Hyunwook Kim, Choong-Kun Lee, Hyo Song Kim, Sun Young Rha, Gyu Young Pih, Yoon Jin Choi and 12 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of gastric cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Global trends in artificial intelligence applications for gastric cancer prediction, treatment, and management: a topic modeling and bibliometric analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Moonki Hong *Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-9528-4912
Mingee Choi *Department of Healthcare Management, Graduate School of Public Health, Yonsei University, Seoul, Korea.ORCID https://orcid.org/0000-0001-9383-6402
JiHyun LeeDivision of Medical Oncology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-5798-0108
Kyoo Hyun KimDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-7871-2142
Hyunwook KimDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-9560-4768
Choong-Kun LeeDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5151-5096
Hyo Song KimDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-0625-9828
Sun Young RhaDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2512-4531
Gyu Young PihDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-6051-8691
Yoon Jin ChoiDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-1922-9388
Da Hyun JungDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-6668-3113
Jun Chul ParkDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-8018-0010
Sung Kwan ShinDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-5466-1400
Sang Kil LeeDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-0721-0364
Yong Chan LeeDivision of Gastroenterology, Department of Internal Medicine, Severance Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0001-8800-6906
Minah ChoDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3011-5813
Yoo Min KimDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5176-804X
Hyoung-Il KimDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-6134-4523
Jae-Ho CheongDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-1703-1781
Woo Jin HyungDepartment of Surgery, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8593-9214
Jaeyong ShinDepartment of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2955-6382
Minkyu JungDivision of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8281-3387
Yonsei University · KRSeverance Hospital · KRSt. Mary's Hospital · USYonsei University Health System · KR

Funding

Korea Foundation for Cancer Research CB-2020-B-1
6 · The paper itself

Abstract

purposeGastric cancer (GC) is among the most prevalent and fatal cancers worldwide. National cancer screening programs in countries with high incidences of this disease provide medical aid beneficiaries with free-of-charge screening involving upper endoscopy to detect early-stage GC. However, the coronavirus disease 2019 (COVID-19) pandemic has caused major disruptions to routine healthcare access. Thus, this study aimed to assess the impact of COVID-19 on the diagnosis, overall incidence, and stage distribution of GC. MATERIALS AND

methodsWe identified patients in our hospital cancer registry who were diagnosed with GC between January 2018 and December 2021 and compared the cancer stage at diagnosis before and during the COVID-19 pandemic. Subgroup analyses were conducted according to age and sex. The years 2018 and 2019 were defined as the "before COVID" period, and the years 2020 and 2021 as the "during COVID" period.

resultsOverall, 10,875 patients were evaluated; 6,535 and 4,340 patients were diagnosed before and during the COVID-19 period, respectively. The number of diagnoses was lower during the COVID-19 pandemic (189 patients/month vs. 264 patients/month) than before it. Notably, the proportion of patients with stages 3 or 4 GC in 2021 was higher among men and patients aged ≥40 years.

conclusionsDuring the COVID-19 pandemic, the overall number of GC diagnoses decreased significantly in a single institute. Moreover, GCs were in more advanced stages at the time of diagnosis. Further studies are required to elucidate the relationship between the COVID-19 pandemic and the delay in the detection of GC worldwide.

Indexed as

COVID-19Gastric cancerIncidenceStomach neoplasms

Identifiers

PMID37932224
PMCPMC10630563
OpenAlexW4388157107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.